Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Evaluation of the Safety and Efficacy of Moxifloxacin Ophthalmic Solution 0.5% Versus Ofloxacin Ophthalmic Solution 0.3% in the Treatment of Bacterial Conjunctivitis in Chinese Patients

NCT01573910 is registered in ClinicalTrials.gov with Alcon Research as lead sponsor.

NCT NCT01573910
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01573910 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Evaluation of the Safety and Efficacy of Moxifloxacin Ophthalmic Solution 0.5% Versus Ofloxacin Ophthalmic Solution 0.3% in the Treatment of Bacterial Conjunctivitis in Chinese Patients
Lead sponsor
Alcon Research
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2012
Completion date
April 30, 2014
Enrollment
985 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bacterial conjunctivitis